OMB nominee advises Senate committee not to 'read too much into' his description of Social Security as a 'Ponzi scheme'
 
At his Senate confirmation hearing Tuesday, Rep. Mick Mulvaney (R-S.C.), President Trump's nominee for director of the Office of Management and Budget, clarified that he does not think Social Security or Medicare are "unconstitutional" — despite his vote in the South Carolina Senate in 2009 declaring both programs exactly that. He also reassured the Senate Budget Committee that his description of Social Security as a "Ponzi scheme" was simply a way of explaining the program's cash flow. "I wouldn't read too much into [my] description of it as a Ponzi scheme," Mulvaney said.
However, while Mulvaney said he would not "be arguing to the president of the United States" that either of those programs are "unconstitutional," he did indicate he would push Trump to make changes to entitlement programs, which Trump has promised not to cut. "The only thing I know to do is tell the president the truth," Mulvaney said, arguing that the programs are not sustainable and that funds would soon run dry; he suggested means-testing Medicare or raising the retirement age for Social Security.
Even before Mulvaney's hearing began, Sen. Bernie Sanders (I-Vt.) was tweeting his concerns, suggesting Mulvaney's nomination meant Trump "doesn't intend to not cut Social Security, Medicare, or Medicaid":
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
 
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Watch Sanders question Mulvaney below. Becca Stanek
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
- 
 Testosterone therapy in women highlights the lack of women’s health research Testosterone therapy in women highlights the lack of women’s health researchThe explainer There is no FDA-approved testosterone product for women 
- 
 Magazine solutions - November 7, 2025 Magazine solutions - November 7, 2025Puzzles and Quizzes Issue - November 7, 2025 
- 
 Magazine printables - November 7, 2025 Magazine printables - November 7, 2025Puzzles and Quizzes Issue - November 7, 2025 
- 
 Nobody seems surprised Wagner's Prigozhin died under suspicious circumstances Nobody seems surprised Wagner's Prigozhin died under suspicious circumstancesSpeed Read 
- 
 Western mountain climbers allegedly left Pakistani porter to die on K2 Western mountain climbers allegedly left Pakistani porter to die on K2Speed Read 
- 
 'Circular saw blades' divide controversial Rio Grande buoys installed by Texas governor 'Circular saw blades' divide controversial Rio Grande buoys installed by Texas governorSpeed Read 
- 
 Los Angeles city workers stage 1-day walkout over labor conditions Los Angeles city workers stage 1-day walkout over labor conditionsSpeed Read 
- 
 Mega Millions jackpot climbs to an estimated $1.55 billion Mega Millions jackpot climbs to an estimated $1.55 billionSpeed Read 
- 
 Bangladesh dealing with worst dengue fever outbreak on record Bangladesh dealing with worst dengue fever outbreak on recordSpeed Read 
- 
 Glacial outburst flooding in Juneau destroys homes Glacial outburst flooding in Juneau destroys homesSpeed Read 
- 
 Scotland seeking 'monster hunters' to search for fabled Loch Ness creature Scotland seeking 'monster hunters' to search for fabled Loch Ness creatureSpeed Read